Health Products and Technologies
The Kenyan Health Sector has been playing a critical role in providing health care services in response to the population needs in line with the Kenya Health Policy, 2014-2030’s goal of attaining the highest possible health standards in a manner responsive to the population needs. Overall, the Health Sector strategic focus guided by the Country’s blueprint, Vision 2030 and the Constitution of Kenya, 2010. The Kenya Vision 2030 aims to transform Kenya into a globally competitive and prosperous country with a high quality of life by 2030, while the Constitution of Kenya, 2010, guarantees the highest attainable standard of health as a right. The policy direction envisages that investments in health systems will be scaled up for improved health outcomes. One of the eight orientations/investment areas of the Kenya Health Policy (KHP) is Health Products and Technologies (HPT).
Read MoreAbout HPT
The HPT investment area seeks to ensure that effective, safe, and affordable health products and technologies are available and rationally used, while maintaining a strategic national health products and technologies (HPT) reserve. Policy direction regarding HPT is further elaborated in the Kenya National Pharmaceutical Policy of 2012 . However, in line with the increased focus through the Universal Health Coverage (UHC) and the Sustainable Development Goals at the global level, this strategy seeks to provide clear direction on HPT supply chain agenda.
Regulation, Policy & Governance
A review of the policy, legal and governance environment reveals that the improvement of procurement and availability of essential HPT is one of the priority reform areas for the health sector in Kenya Vision 2030. Scaling up of investment in HPT is one of the anchors for the achievement of the six health objectives/outcomes of the Kenya Health Policy 2014-2030 (Sessional Paper 7 of 2012), the overarching framework guiding the nation towards attainment of the highest standard in a manner that is responsive to the need of the population.
What we do
The HPT investment area seeks to ensure that effective, safe, and affordable health products and technologies are available and rationally used, while maintaining a strategic national health products and technologies (HPT) reserve. Policy direction regarding HPT is further elaborated in the Kenya National Pharmaceutical Policy of 2012 whose implementation pace has been slow. However, in line with the increased focus through the Universal Health Coverage (UHC) and the Sustainable Development Goals at the global level, this strategy seeks to provide clear direction on HPT supply chain agenda.
Policies, guidelines and legal frameworks to guide the process of procurement and quality of drugs at both tiers of the governments will be institutionalized to ensure availability and rational drugs use.
Policies, guidelines and legal frameworks HPT supply chain strategy.
Transparency and accountability
Defining and applying an evidenced based essential package of health products and technologies.
Resource management
Promoting local production, research and innovation of essential health products and technologies.
Appraisal
Establishing rational appraisal mechanism for health product and technologies.
Our Partners
The HPT division seeks to ensure effective, safe, and affordable health products and technologies are available and rationally used.
Latest News
-
March 17, 2021
HPT dashboard on UHC commodities release
-
February 9, 2021
HPT supply chain strategy 2020-2025.
Contact us
Ministry of Health, Afya HouseP.O. Box:30016–00100, Nairobi, Kenya Email : pharmacyhpt@health.go.ke, ps@health.go.ke Phones : Main: (254) 20 - 2717 077